Treatment and survival of Medicare beneficiaries with colorectal cancer: a comparative analysis between a rural state cancer registry and national data.
Rane PB, Madhavan SS, Sambamoorthi U, Sita K, Kurian S, Pan X.
Popul Health Manag. 2017; 20(1): 55-65.
PMC Journal - In Process
Radiation exposure from diagnostic procedures in patients with newly diagnosed breast cancer.
Chaudhary LN, Knapp S, Wen S, Xiao J, Marano GD, Kurian S, Layne G, Jacobson GM, Abraham J.
J Community Support Oncol. 2015;13(1):27-29.
Exercise and dietary advice intervention for survivors of triple-negative breast cancer: effects on body fat, physical function, quality of life, and adipokine profile.
Swisher AK, Abraham J, Bonner D, Gilleland D, Hobbs GR, Kurian S, Yanosik MA, Vona-Davis LC.
Support Care Cancer. 2015;23(10):2995-3003.
Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients.
Chaudhary LN, Wen S, Xiao J, Swisher AK, Kurian S, Abraham J.
J Community Support Oncol. 2014;12(10):355-360.
Health behaviors among breast, prostate, and colorectal cancer survivors: a US population-based case-control study, with comparisons by cancer type and gender.
Lemasters TJ, Madhavan SS, Sambamoorthi U, Kurian S.
J Cancer Surviv. 2014; [Epub ahead of print]
Breast cancer pathology, receptor status, and patterns of metastasis in a rural Appalachian population.
Vona-Davis LC, Rose DP, Gadiyaram V, Ducatman BS, Hobbs GR, Hazard HW, Kurian S, Abraham J.
J Cancer Epidemiol. 2014;2014:170634
Bone marrow osteoblast vulnerability to chemotherapy.
Gencheva M, Hare I, Kurian S, Fortney JE, Piktel D, Wysolmerski RB, Gibson LF.
Eur J Haematol. 2013;90(6):469-478.
A population-based study comparing HRQoL among breast, prostate, and colorectal cancer survivors to propensity score matched controls, by cancer type, and gender.
Lemasters T, Madhavan SS, Sambamoorthi U, Kurian S.
Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways.
Provenzano A, Kurian S, Abraham J.
Expert Rev Anticancer Ther. 2013;13(2):143-147.
Initial clinical test of a breast-PET scanner.
Raylman RR, Abraham J, Hazard HW, Koren C, Filburn S, Schreiman JS, Kurian S, Majewski S, Marano GD.
J Med Imaging Radiat Oncol. 2011;55(1):58-64.
Prognostic significance of the "surprise" question in cancer patients.
Moss AH, Lunney JR, Culp SL, Auber ML, Kurian S, Rogers JS, Dower JM, Abraham J.
J Palliat Med. 2010;13(7):837-840.